China Biopharmaceutical: trustee buys approximately HK $45.96 million of shares in respect of restricted share incentive scheme

[China Biopharmaceutical: trustee buys about HK $45.96 million of shares for restricted share Award Scheme] China Biopharmaceutical (01177.HK) issued an announcement that on that day the trustee purchased a further 12 million shares from the market and held them in trust on behalf of the selected participants in accordance with the terms and conditions of the scheme rules. The average consideration per share is about HK $3.83 and the total consideration for the purchase of shares is about HK $45.96 million.